SNT
Click for more information
25.7% 4.4¢ syntara limited

Ann: FDA Meeting, Business Review Announcement En, page-3

  1. Neo
    2,195 Posts.
    clock Created with Sketch.
    14/05/13
    13:06
    Post #: 11761065
    re: Ann: FDA Meeting, Business Review Announc... Primaus,

    Don't forget it's likely going to be a restricted approval, so in the US there is 30,000 patients, however only half are over 18.

    Also remember they could very well now be competing with Vertex for market share/ FDA approval, with Vertex looking to gain approval to treat 50% of the CF population...

    PXS Price at posting: 15.5¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Buying smarter as baby boomers get boost
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
NEWS Hillcrest Energy Unveils Power Factor Correction Prototype to Meet Growing Demand
right-arrow Created with Sketch.
NEWS What matters for FY25: Investment; interest rates; inflation & elections
right-arrow Created with Sketch.
FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
GED Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
4.4¢ 		Change
0.009(25.7%) 		Mkt cap ! $52.53M
Open High Low Value Volume
3.6¢ 4.4¢ 3.6¢ $183.9K 4.656M

Buyers (Bids)

No. Vol. Price($)
1 1159 4.1¢
 

Sellers (Offers)

Price($) Vol. No.
4.4¢ 997342 3
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.